Comparative statistics by cancer registry
Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
(Karunagappally, India, 1991-1997 cases followed-up until 1999)Click on cancer site (ICD-10 code) for comparison
| % | No. of excluded cases | Included cases | |||||||||
| Site | ICD-10 | Total registered | HV | DCO | DCO | No. follow-up | Others | Total | % | No. | % |
| C01-02 | Tongue | 88 | 83.0 | 1.1 | 1 | 1 | 0 | 2 | 2.3 | 86 | 97.7 |
| C03-06 | Oral cavity | 130 | 82.3 | 3.1 | 4 | 2 | 1 | 7 | 5.4 | 123 | 94.6 |
| C12-13 | Hypopharynx | 33 | 93.9 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 33 | 100.0 |
| C15 | Oesophagus | 111 | 70.3 | 1.8 | 2 | 2 | 1 | 5 | 4.5 | 106 | 95.5 |
| C16 | Stomach | 86 | 50.0 | 8.1 | 7 | 2 | 0 | 9 | 10.5 | 77 | 89.5 |
| C19-20 | Rectum | 39 | 76.9 | 2.6 | 1 | 0 | 0 | 1 | 2.6 | 38 | 97.4 |
| C22 | Liver | 55 | 76.4 | 1.8 | 1 | 0 | 0 | 1 | 1.8 | 54 | 98.2 |
| C25 | Pancreas | 41 | 39.0 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 41 | 100.0 |
| C32 | Larynx | 48 | 87.5 | 2.1 | 1 | 1 | 0 | 2 | 4.2 | 46 | 95.8 |
| C33-34 | Lung | 248 | 56.9 | 7.7 | 19 | 5 | 4 | 28 | 11.3 | 220 | 88.7 |
| C44 | Other skin | 28 | 100.0 | 0.0 | 0 | 1 | 0 | 1 | 3.6 | 27 | 96.4 |
| C50 | Breast | 193 | 93.8 | 1.0 | 2 | 1 | 0 | 3 | 1.6 | 190 | 98.4 |
| C53 | Cervix | 180 | 85.0 | 3.9 | 7 | 3 | 0 | 10 | 5.6 | 170 | 94.4 |
| C56 | Ovary | 35 | 88.6 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 35 | 100.0 |
| C61 | Prostate | 34 | 67.6 | 0.0 | 0 | 2 | 0 | 2 | 5.9 | 32 | 94.1 |
| C67 | Urinary bladder | 39 | 79.5 | 0.0 | 0 | 0 | 1 | 1 | 2.6 | 38 | 97.4 |
| C70-72 | Brain & nervous system | 61 | 50.8 | 24.6 | 15 | 0 | 0 | 15 | 24.6 | 46 | 75.4 |
| C73 | Thyroid | 75 | 92.0 | 1.3 | 1 | 0 | 0 | 1 | 1.3 | 74 | 98.7 |
| C82-85+C96 | Non-Hodgkin lymphoma | 69 | 100.0 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 69 | 100.0 |
| C90 | Multiple myeloma | 28 | 89.3 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 28 | 100.0 |
| C91 | Lymphoid leukaemia | 38 | 100.0 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 38 | 100.0 |
| C92-94 | Myeloid leukaemia | 30 | 100.0 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 30 | 100.0 |
Other tables available for this registry:
| - Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Karunagappally, India, 1991-1997 cases followed-up until 1999) |
| - Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Karunagappally, India, 1991-1997 cases followed-up until 1999) |
| - Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Karunagappally, India, 1991-1997 cases followed-up until 1999) |
| - Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Karunagappally, India, 1991-1997 cases followed-up until 1999) |
| - Table5b: | Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Karunagappally, India, 1991-1997) |
Registry chapter:
 | Consult the chapter in Cancer survival in developping countries (Volume II) |